CANY
ACH

Caxton Associates (New York)’s Accendra Health ACH Stock Holding History

Caxton Associates (New York)’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-15,227
Closed -$139K – 580
2020
Q1 		$139K Buy
+15,227
New +$91.9K 0.03% 375
2019
Q2 		– Sell
-11,521
Closed -$47K – 497
2019
Q1 		$47K Sell
11,521
-32,473
-74% -$205K 0.01% 364
2018
Q4 		$278K Buy
+43,994
New +$457K 0.04% 198
2017
Q3 		– Sell
-18,508
Closed -$596K – 589
2017
Q2 		$596K Buy
+18,508
New +$607K 0.02% 266

Other funds holding ACH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SGCIA
Smith Graham & Co Investment Advisors Houston, Texas $868M AUM 24.69% 1-Year Est. Return

Caxton Associates (New York)'s ACH Position: Q2 2020 in Review

Caxton Associates (New York) sold out of Accendra Health (ACH) in Q2 2020, closing a stake of 15,227 shares — an estimated $139K sold.

Caxton Associates (New York) first reported a position in ACH in Q2 2017 and held it in 4 quarters. The position peaked at $596K in Q2 2017. 188 funds tracked by Wall St. Rank hold ACH as of Q2 2020.

  • Caxton Associates (New York) reported no remaining Accendra Health position as of Q2 2020 after selling out during the quarter.
  • Caxton Associates (New York) sold 15,227 Accendra Health shares in Q2 2020, an estimated $139K.
  • Caxton Associates (New York) first reported a position in Accendra Health in Q2 2017 and held it in 4 quarters.
  • Caxton Associates (New York)'s Accendra Health position peaked at $596K in Q2 2017.
  • 188 funds tracked by Wall St. Rank held Accendra Health as of Q2 2020.

Based on Caxton Associates (New York)'s 13F filing for Q2 2020, filed 14 Aug 2020.